On Thursday night we received the main price in the biggest German business plan competition, awarded by the Executive Board of Sanofi Aventis and the Minister for Economic Affairs of the Federal State of Hesse.
Yesterday we received the main price at the AC2 Gründerwettbewerb, one of the most renown business plan competitions in Germany with a strong focus on technology Start-Ups. We are thus among the TOP 10 out of 100 participating companies and are looking forward to the final round.
Last week, aquila biolabs was invited at the Aachen Technology and Entrepreneurship Conference (ATEC), where technology based Start-Ups meet with investors to discuss their ideas. One of the highlights was the annual pitch contest, in which different Start-Ups competed for the highest investment and where we scored the second place among the five contenders.
aquila biolabs was recently featured in a short article on promising Biotech Start-Ups by Dina Titkova from the Swedish Karolinska Institute. Read here what Daniel and Jens have to say about current challenges, plans for the future and the adventure of starting your own business. Read the article here
As of today we are officially sponsored by the German Federal Ministry for Economic Affairs and Energy, pursuant to a decision of the German Parliament, as well as the European Union. In the course of the EXIST scholarship we will be funded with a volume of 100.000 €, laboratory infrastructure and supported by experienced mentors.